[Still questions around the slimming agent rimobant. Not approved in USA because of the risk of mental adverse effects].
Wettermark
Björn
B
Läkemedelscentrum, Stockholms.
Raaschou
Pauline
P
Forslund
Tomas
T
Hjemdahl
Paul
P
D019440:Anti-Obesity Agents / Q000009:adverse effects*; D063387:Cannabinoid Receptor Antagonists; D003863:Depression / Q000139:chemically induced*; D017277:Drug Approval; D006801:Humans; D009765:Obesity / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D000077285:Rimonabant; D012307:Risk Factors; D015431:Weight Loss / Q000187:drug effects
D019440:Anti-Obesity Agents; D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant